Tocotrienols, inflammation, and cancer: How are they linked?

Sahdeo Prasad, Bokyung Sung, Sridevi Patchva, Subash C. Gupta, Bharat B. Aggarwal

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In 1900, the top three causes of death in the United States were pneumonia/influenza, tuberculosis, and diarrhea/enteritis. Since the 1940s, however, most deaths in the United States have resulted from heart disease and cancer (NCHS 1900, 1948). Cancer is the second most common cause of death in the United States, after heart disease. Since 1950, the incidence of heart diseases has sharply decreased, but cancer incidence has not declined. It has been estimated that in the year 2011, about 1,596,670 new cancer cases will be diagnosed and about 571,950 Americans are expected to die of cancer, or more than 1500 people a day. In the United States, cancer accounts for nearly one of every four deaths. According to the International Agency for Research on Cancer (IARC), by the year 2030, almost 21.4 million new cases of this disease will be diagnosed annually and >13.2 million people will die of cancer each year, almost double the number who died of the disease in 2008. Therefore, it is necessary to better understand the prognosis, diagnosis, and treatment of cancer.

Original languageEnglish (US)
Title of host publicationTocotrienols
Subtitle of host publicationVitamin E beyond Tocopherols, Second Edition
PublisherCRC Press
Pages209-224
Number of pages16
ISBN (Electronic)9781439884430
ISBN (Print)9781439884416
DOIs
StatePublished - Jan 1 2012

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology
  • General Engineering
  • General Agricultural and Biological Sciences

Fingerprint

Dive into the research topics of 'Tocotrienols, inflammation, and cancer: How are they linked?'. Together they form a unique fingerprint.

Cite this